
JLL IPT Expands Life Sciences Holdings with NJ Property
JLL Income Property Trust has acquired 170 Park Ave., a 147,000-square-foot, purpose-built life sciences building in Florham Park, NJ, for $46.6 million. The property is net-leased on a long-term basis as premier laboratory space and the corporate headquarters for Celularity Inc., a clinical-stage biotechnology company.
“Within the office sector our priority investments are healthcare oriented, focusing on medical office and life science properties,” said Allan Swaringen, president and CEO of JLL IPT.
He added, “While we are excited about expanding our healthcare allocation, we were also attracted to acquiring 170 Park Ave. significantly below replacement cost and with tenant and prior owner-funded improvements to the building in excess of $80 million.”
Jeffrey Dunne, Jeremy Neuer, Steve Bardsley, David Gavin, Gene Pride, Travis Langer and Zach McHale of CBRE’s Institutional Properties group, in partnership with CBRE’s Tom Sullivan, represented an institutional seller in the sale and also obtained the buyer.
- ◦Acquisition